CGEN
Price
$1.74
Change
+$0.03 (+1.75%)
Updated
Jun 6 closing price
Capitalization
157.2M
54 days until earnings call
OCS
Price
$19.92
Change
+$0.36 (+1.84%)
Updated
Jun 6 closing price
Capitalization
1.04B
Interact to see
Advertisement

CGEN vs OCS

Header iconCGEN vs OCS Comparison
Open Charts CGEN vs OCSBanner chart's image
Compugen
Price$1.74
Change+$0.03 (+1.75%)
Volume$232.3K
Capitalization157.2M
Oculis Holding AG
Price$19.92
Change+$0.36 (+1.84%)
Volume$42.61K
Capitalization1.04B
CGEN vs OCS Comparison Chart
Loading...
CGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGEN vs. OCS commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGEN is a Hold and OCS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (CGEN: $1.74 vs. OCS: $19.92)
Brand notoriety: CGEN and OCS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGEN: 89% vs. OCS: 118%
Market capitalization -- CGEN: $157.2M vs. OCS: $1.04B
CGEN [@Biotechnology] is valued at $157.2M. OCS’s [@Biotechnology] market capitalization is $1.04B. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGEN’s FA Score shows that 1 FA rating(s) are green whileOCS’s FA Score has 0 green FA rating(s).

  • CGEN’s FA Score: 1 green, 4 red.
  • OCS’s FA Score: 0 green, 5 red.
According to our system of comparison, CGEN is a better buy in the long-term than OCS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGEN’s TA Score shows that 6 TA indicator(s) are bullish while OCS’s TA Score has 6 bullish TA indicator(s).

  • CGEN’s TA Score: 6 bullish, 3 bearish.
  • OCS’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, both CGEN and OCS are a good buy in the short-term.

Price Growth

CGEN (@Biotechnology) experienced а +18.37% price change this week, while OCS (@Biotechnology) price change was +2.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

CGEN is expected to report earnings on Jul 31, 2025.

OCS is expected to report earnings on Mar 11, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCS($1.04B) has a higher market cap than CGEN($157M). CGEN (64.00) and OCS (63.08) have similar P/E ratio . OCS YTD gains are higher at: 17.176 vs. CGEN (13.725). CGEN has higher annual earnings (EBITDA): -14.41M vs. OCS (-101.78M). OCS has more cash in the bank: 182M vs. CGEN (103M). OCS has less debt than CGEN: OCS (1.1M) vs CGEN (2.91M). CGEN has higher revenues than OCS: CGEN (27.9M) vs OCS (0).
CGENOCSCGEN / OCS
Capitalization157M1.04B15%
EBITDA-14.41M-101.78M14%
Gain YTD13.72517.17680%
P/E Ratio64.0063.08101%
Revenue27.9M0-
Total Cash103M182M57%
Total Debt2.91M1.1M264%
FUNDAMENTALS RATINGS
CGEN: Fundamental Ratings
CGEN
OUTLOOK RATING
1..100
28
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
21
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGENOCS
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
36%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
53%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
66%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
50%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
55%
Advances
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 1 day ago
72%
Declines
ODDS (%)
N/A
Bearish Trend 6 days ago
63%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
36%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
53%
View a ticker or compare two or three
Interact to see
Advertisement
CGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JIUCX16.52N/A
N/A
JPMorgan Developed International Value C
LIDCX9.36N/A
N/A
Lord Abbett International Value C
AZNCX9.52N/A
N/A
Virtus Income & Growth C
SBQUX12.25N/A
N/A
AmericaFirst Alpha Trends Factor Class U
BSCRX16.21N/A
N/A
Brandes Small Cap Value R6

OCS and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCS has been loosely correlated with CUE. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if OCS jumps, then CUE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCS
1D Price
Change %
OCS100%
+1.84%
CUE - OCS
33%
Loosely correlated
+1.73%
SNSE - OCS
33%
Loosely correlated
-4.65%
PRAX - OCS
29%
Poorly correlated
+5.44%
CGEN - OCS
27%
Poorly correlated
+1.75%
GRI - OCS
27%
Poorly correlated
-3.50%
More